HS Spinco, Inc. Files Registration Statement With U.S. Securities And Exchange Commission For Spin Off Of Henry Schein's Animal Health Business And Subsequent Merger With Vets First Choice

MELVILLE, N.Y., Dec. 26, 2018 /PRNewswire/ --AHenry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that HS Spinco, Inc. ("Spinco") has filed a registration statement on Form S-4/S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the planned spin off of theAHenry Schein Animal HealthAbusiness and the subsequent merger with Vets First Choice. Spinco intends to list its common stock on the Nasdaq Global Select Market under the symbol "CVET" and the new standalone company will be named Covetrus. Investors may find an electronic copy of Spinco's registration statement at . Additional Information and Where to Find It
A registration statement on Form S-1/S-4 relating to this transaction has been filed with the SEC,Abut has not yet become effective.AThe number of shares to be offered and distribution ratios have not been determined. Investors and security holders are urged to carefully read the registration statement and preliminary prospectus (including any amendments or supplements thereto and any documents incorporated by reference therein) and any other relevant documents filed with theASECAwhen they become available, because they will contain important information about the parties and the proposed transaction.AThe registration statement, preliminary prospectus and other relevant documents that are filed with theASEC, when available,Acan be obtained free of charge from theASEC'sAweb site atA. These documents, when available, can also be obtained free of charge fromAHenry Schein, Inc.Aupon written request toACarolynne BordersAatAHenry Schein, Inc.,A135 Duryea Road,AMelville, NYA11747. This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The proposed offering will be made only by means of a prospectus meeting the requirements of SectionA10 of the Securities Act of 1933, as amended.Forward-Looking Statements
In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, the parties provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate" or other comparable terms. Such forward-looking statements include, but are not limited to, statements about the benefits of the transaction, including future financial and operating results, plans, objectives, expectations and intentions. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future a?? including statements relating to anticipated synergies and the expected timetable for completing the proposed transaction a?? are forward-looking statements. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. Therefore, you should not rely on any of these forward-looking statements.AThese forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. For example, these forward-looking statements could be affected by factors including, without limitation, risks associated with the ability to consummate the transaction and the timing of the closing of the transaction; the ability to obtain requisite approvals; the ability to successfully integrate operations and employees; the ability to realize anticipated benefits and synergies of the transaction; the potential impact of the announcement of the transaction or consummation of the transaction on relationships, including with employees, customers and competitors; the ability to retain key personnel; the ability to achieve performance targets; changes in financial markets, interest rates and foreign currency exchange rates; and those additional risks and factors discussed in the registration statement on Form S-1/S-4 filed with theASECA, including those discussed under the heading "Risk Factors" in the registration statement. We undertake no duty and have no obligation to update any forward-looking statements contained herein.About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a health solutions network powered by people and technology. With more than 22,000AAserving more than 1 million customers globally, the Company is the world's largest provider of Business, Clinical, Technology, and Supply Chain solutions to enhance the efficiency of office-basedA,A,AandAApractitioners. The Company also servesA,A, and other alternate care sites.AA Fortune 500A Company and a member of theAS&PA500A and the Nasdaq 100A indexes, Henry Schein's network of trusted advisors provides health care professionals with the valued solutions they need to improve operational success and clinical outcomes. The Company offers customers exclusive, innovative products and solutions, including practice management software, e-commerce solutions, specialty and surgical products, as well as a broad range ofA. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.Headquartered inAMelville, N.Y., Henry Schein has operations or affiliates in 34 countries.AThe company's sales reached a recordA$12.5 billionAin 2017, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein atA,A, andA.A
HS Spinco, Inc. Files Registration Statement With U.S. Securities And Exchange Commission For Spin Off Of Henry Schein's Animal Health Business And Subsequent Merger With Vets First Choice
View original content:SOURCE Henry Schein, Inc.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«     2020    »